KalVista Pharmaceuticals (KALV) Reports Q1 Loss of $0.47/Share

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q1 EPS of ($0.47), versus ($0.51) reported last year. Revenue for the quarter came in at $3.7 million, versus $10 thousand reported last year.

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c